US Edition
Synergistic Potential of Bone Marrow Mesenchymal Stem Cells and mir181-A Combinational Therapy against Multiple Sclerosis
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Synergistic Potential of Bone Marrow Mesenchymal Stem Cells and mir181-A Combinational Therapy against Multiple Sclerosis
Researchers proposed a synergistic therapy approach that combines the penetrative targeting capability of bone marrow MSCs (BMSCs) with the immuno-modulatory effects of miR181-a by overexpressing miR181-a to BMSCs through lentivirus packaging system. [Stem Cell Research & Therapy] Full Article
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
